Dapagliflozin — Advanced Blood Sugar Control

Dapagliflozin is a modern SGLT2 inhibitor widely used for the treatment of type 2 diabetes mellitus. It works by blocking glucose reabsorption in the kidneys, promoting the excretion of glucose through urine, and thereby effectively lowering blood glucose levels.

Clinical Applications

• Management of type 2 diabetes

• Support for glycemic control

• Adjunct therapy for patients with cardiovascular or renal risk factors

Quality and Manufacturing

Changzhou Ruiming Pharmaceutical Co., Ltd. ensures all production and quality management procedures strictly follow GMP standards, guaranteeing safe, effective, and consistent Dapagliflozin products.

R&D and Innovation

With a highly skilled R&D team and partnerships with China Pharmaceutical University and leading Shanghai universities, Ruiming Pharmaceutical continuously enhances product technology, focusing on innovation and advanced therapeutics.

Global Collaboration

The company welcomes international partnerships, inviting clients worldwide to explore cooperation opportunities, achieve mutual growth, and develop long-term, trust-based relationships.